-
Something wrong with this record ?
Optimization of right ventricular lead position in cardiac resynchronisation therapy
L Riedlbauchova, R Cihak, J Bytesnik, V Vancura, P Fridl, L Hoskova, J Kautzner
Language English Country Netherlands
Grant support
NR8541
MZ0
CEP Register
Digital library NLK
Full text - Article
Source
NLK
Medline Complete (EBSCOhost)
from 2000-03-01 to 1 year ago
Wiley Free Content
from 1999 to 1 year ago
BACKGROUND: The benefit of biventricular pacing (BiV) may be substantially affected by optimal lead placement. AIM: To evaluate the importance of right ventricular (RV) lead positioning on clinical outcome of BiV. METHODS AND RESULTS: A total of 99 patients with symptomatic heart failure and implantation of BiV system were included. Position of the left-ventricular (LV) lead was selected based on timing of local endocardial signal within the terminal portion of the QRS complex. RV lead was preferably positioned at the midseptum (n=74, RVS group) where the earliest RV endocardial signal was recorded. A subgroup of patients had RV lead placed in the apex (n=25, RVA group). NYHA class, maximum oxygen-uptake (VO(2)max), LV end-diastolic diameter (LVEDD, mm) and ejection fraction were assessed every third month. A trend towards greater improvement in NYHA class and significant increase in VO(2)max was present in the RVS group. Moreover, a significant decrease in LVEDD (DeltaLVEDD) was observed in the RVS group only (-3.4+/-6.5 mm versus +1.7+/-6.4 mm in RVA group at 12 months, p=0.004). No significant correlation between the degree of DeltaLVEDD and QRS narrowing induced by BiV was found. LVEDD reduction was predominantly present in dilated cardiomyopathy. CONCLUSIONS: Midseptal positioning of the RV lead appears to promote reverse LV remodelling during cardiac resynchronisation therapy.
References provided by Crossref.org
Literatura
- 000
- 00000naa a2200000 a 4500
- 001
- bmc13032000
- 003
- CZ-PrNML
- 005
- 20131002143759.0
- 007
- ta
- 008
- 131002s2006 ne a f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.ejheart.2005.11.009 $2 doi
- 035 __
- $a (PubMed)16504581
- 040 __
- $a ABA008 $d ABA008 $e AACR2 $b cze
- 041 0_
- $a eng
- 044 __
- $a ne
- 100 1_
- $a Riedlbauchová, Lucie, $d 1976- $7 xx0109046 $u Department of Cardiology, Institute for Clinical and Experimental Medicine, Prague, Czech Republic
- 245 10
- $a Optimization of right ventricular lead position in cardiac resynchronisation therapy / $c L Riedlbauchova, R Cihak, J Bytesnik, V Vancura, P Fridl, L Hoskova, J Kautzner
- 504 __
- $a Literatura
- 520 9_
- $a BACKGROUND: The benefit of biventricular pacing (BiV) may be substantially affected by optimal lead placement. AIM: To evaluate the importance of right ventricular (RV) lead positioning on clinical outcome of BiV. METHODS AND RESULTS: A total of 99 patients with symptomatic heart failure and implantation of BiV system were included. Position of the left-ventricular (LV) lead was selected based on timing of local endocardial signal within the terminal portion of the QRS complex. RV lead was preferably positioned at the midseptum (n=74, RVS group) where the earliest RV endocardial signal was recorded. A subgroup of patients had RV lead placed in the apex (n=25, RVA group). NYHA class, maximum oxygen-uptake (VO(2)max), LV end-diastolic diameter (LVEDD, mm) and ejection fraction were assessed every third month. A trend towards greater improvement in NYHA class and significant increase in VO(2)max was present in the RVS group. Moreover, a significant decrease in LVEDD (DeltaLVEDD) was observed in the RVS group only (-3.4+/-6.5 mm versus +1.7+/-6.4 mm in RVA group at 12 months, p=0.004). No significant correlation between the degree of DeltaLVEDD and QRS narrowing induced by BiV was found. LVEDD reduction was predominantly present in dilated cardiomyopathy. CONCLUSIONS: Midseptal positioning of the RV lead appears to promote reverse LV remodelling during cardiac resynchronisation therapy.
- 590 __
- $a bohemika - dle Pubmed
- 650 12
- $a Cardiac Output, Low $x th [Therapy]
- 650 12
- $a Cardiac Pacing, Artificial $x mt [Methods]
- 650 02
- $a Chronic Disease
- 650 02
- $a Electrodes, Implanted
- 650 02
- $a Female
- 650 12
- $a Heart Septum $x ir [Innervation]
- 650 12
- $a Heart Ventricles $x ir [Innervation]
- 650 _2
- $a lidé $7 D006801
- 650 02
- $a Hypertrophy, Left Ventricular $x pc [Prevention & Control]
- 650 02
- $a Male
- 650 02
- $a Middle Aged
- 650 12
- $a Pacemaker, Artificial
- 650 02
- $a Prospective Studies
- 650 02
- $a Ventricular Remodeling
- 700 1_
- $a Čihák, Robert $7 xx0061374 $u Department of Cardiology, Institute for Clinical and Experimental Medicine, Prague, Czech Republic
- 700 1_
- $a Bytešník, Jan, $d 1947- $7 jn20000400328 $u Department of Cardiology, Institute for Clinical and Experimental Medicine, Prague, Czech Republic
- 700 1_
- $a Vančura, Vlastimil $7 xx0060367 $u Department of Cardiology, Institute for Clinical and Experimental Medicine, Prague, Czech Republic
- 700 1_
- $a Frídl, Petr $7 xx0059974 $u Department of Cardiology, Institute for Clinical and Experimental Medicine, Prague, Czech Republic
- 700 1_
- $a Hošková, Lenka $7 xx0076892 $u Department of Cardiology, Institute for Clinical and Experimental Medicine, Prague, Czech Republic
- 700 1_
- $a Kautzner, Josef, $d 1957- $7 xx0037112 $u Department of Cardiology, Institute for Clinical and Experimental Medicine, Prague, Czech Republic
- 773 0_
- $t European Journal of Heart Failure $x 1388-9842 $g Roč. 8, č. 6 (2006), s. 609-614 $p Eur J Heart Fail $w MED00006634
- 773 0_
- $p Eur J Heart Fail $g 8(6):609-14, 2006 Oct $x 1388-9842
- 910 __
- $a ABA008 $y 4 $z 0
- 990 __
- $a 20131002144317 $b ABA008
- 991 __
- $a 20131002144317 $b ABA008
- 999 __
- $a ok $b bmc $g 996086 $s 830448
- BAS __
- $a 3
- BMC __
- $a 2006 $b 8 $c 6 $d 609-614 $i 1388-9842 $m European journal of heart failure $x MED00006634 $n Eur J Heart Fail
- GRA __
- $a NR8541 $p MZ0
- LZP __
- $a 2013-10/išbo